Meine Zukunft Innovative Chemie Interviews Inspirierende Job-Links Meine Ausbildung

ABI's Positions

Austria has been increasingly investing in the development of the biotech community over the last years – and there is still more potential for further development. Nationwide, several centres of excellence were established. To position Austria in the very top among the European countries, the legal  framework has to be improved., in order to enure to the benefit of the Austrian-based  companies, their employees and their customers (who are mainly patients). 

ABI focuses on  three political areas,  where certain measures can be implemented immediately:

  1. Initiatives on all educational levels
  2. Improvement of the system of research support (promotion) for Austria and especially the biotech community
  3. Courageous capital market initiatives and general conditions supporting economic growth

Corresponding documents are available only in the German section.

EuropaBIO SME Award 2013
 
BioEurop2013

more
News Focussing on Members

(IMBA) The fight against genome parasites more

 

(Intercell) Extraordinary General Meeting approved proposed merger of equals with Vivalis SA to create Valneva SE more

 

(acib) Biotechnology connects Slovenia and Austria more

 

(Eucodis) EUCODIS Bioscience and evocatal enter into alliance more 

 

(Intercell) Staph Bakali new Chief Business Officer more 

 

(Intercell) Intercell acquires antibody technology platform to further exploit its capabilities to combat infectious diseases more 

 

(Apeptico) APEPTICO granted Orphan Drug Designation by FDA for development compound AP301 more